[1] Siegel R, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68(1):7-30.
[2] Noone AM, Howlader N, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.
[3] Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Onc 2016;11(1):39-51.
[4] Veeramachaneni NK, Fein RH, Stephenson BJK, LJ Edwards, Fernandez FG. Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America. Ann Thorac Surg 2012;94:922–8
[5] Seder CW, Salati M, Kozower BD, et al. Variation in pulmonary resection practices between the Society of Thoracic Surgeons and the European Society of Thoracic Surgeons General Thoracic Surgery Databases. Ann Thorac Surg 2016;101(6):2077-84.
[6] Albain KS, Swann RS, Rusch VW, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009;374:379-86.
[7] Albain KS, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group Phase II Study 8805. J Clin Oncol 1995;13:1880-92.
[8] van Meerbeeck JP, Kramer GW, Van Schil PE, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 2007;99(6):442-50.
[9] Thomas M, Rübe C, Hoffknecht P, et al. Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. Lancet Oncol 2008;9(7):636-48.
[10] Boffa D, Fernandez FG, Kim S, et al. Surgically managed clinical stage IIIA-clinical N2 lung cancer in the Society of Thoracic Surgeons Database. Ann Thorac Surg 2017;104:395-403.
[11] Fernandez FG, Falcoz PE, Kozower BD, et al. The Society of Thoracic Surgeons and The European Society of Thoracic Surgeons General Thoracic Surgery Databases: joint standardization of variable definitions and terminology. Ann Thorac Surg 2015;99:368–76.
[12] Society of Thoracic Surgeons General Thoracic Surgery Database Training Manual: Version 2.3. Available at
www.sts.org/sites/default/files/documents/August28_v2.3_GTSD_Training_Manual.pdf (Accessed August 27, 2018)
[13] European Society of Thoracic Surgery Annual Database Report (2016). Available at http://www.ests.org/_userfiles/pages/files/ESTS%202016Silver_Book_FULL_FINAL_14.50.pdf (accessed August 27, 2018)
[14] Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest 2009;136:260-271.
[15] Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2013;143(5 Suppl):e211S–50S.
[16] De Leyn P, Dooms C, Kuzdzal J, et al. Revised ESTS guidelines from preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg 2014;45(5)787-98.
[17] Ramnath N, Dilling TJ, Harris LJ, et al. Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2013;143(5 Suppl):e314S–40S.
[18] Blumenthal GM, Bunn PA, Jr., Chaft JE, et al. Current status and future perspectives on neoadjuvant therapy in lung cancer. J Thorac Oncol 2018;13:1818-31.
[19] Brunelli A, Rocco G, Szanto Z, et al. Morbidity and mortality of lobectomy or pneumonectomy after neoadjuvant treatment; an analysis from the ESTS database. Eur J Cardiothorac Surg 2020:57(4)740-46.
[20] Yang CJ, Shah SA, Lin BK, et al. Right-sided versus left-sided pneumonectomy after induction therapy for non-small cell lung cancer. Ann Thorac Surg 2019;107:1074-81.
[21] Email communication with Adelaide Dolan, Database Coordinator, STS National Database.
[22] Email communication with Stefano Passani, MD MHM.